Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Osmosis across the peritoneum" refers to the passive movement of water from the peritoneal capillaries into the peritoneal cavity, primarily driven by an osmotic gradient created during peritoneal dialysis. The movement of water is largely facilitated through the water channel protein aquaporin-1 (AQP-1) present in the capillary endothelium[2][4]. This process is central to peritoneal dialysis, where an osmotic agent (e.g., glucose) in the dialysate creates the gradient necessary for water removal from the body. The three-pore model is commonly used to describe this process, defining three types of pores—ultrasmall (free water via AQP-1), small (water plus small solutes), and large (proteins and larger solutes)—in the microvascular wall of the peritoneal membrane[1][4]. Impairments in this process, such as through loss of osmotic gradient or altered membrane structure, are clinically significant causes of ultrafiltration failure in peritoneal dialysis patients[2][4]. However, "osmosis across the peritoneum" is not a molecular therapeutic target or receptor but a physiological mechanism, and thus not catalogued as a target according to current pharmacological standards. Drugs do not directly interact with osmosis itself, but rather with channels or mechanisms facilitating osmosis (e.g., drugs targeting aquaporin-1). AQP-1 abundance may serve as an indirect biomarker for osmotic water transport efficiency. Safety concerns pertain to manipulation of the process, such as issues related to high glucose dialysate, rather than the process itself. If you seek information on the molecule facilitating this process, refer to "Aquaporin-1 (AQP-1)", which is the main water channel implicated in peritoneal osmosis[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Osmosis across the peritoneum.